Associação de HER2DX com pCR e sobrevida no câncer de mama HER2+ e prevalência de câncer de mama em cirurgiãs ortopédicas

Notas do episódio

Referências: Villacampa G, Tung NM, Pernas S, Paré L, Bueno-Muiño C, Echavarría I, López-Tarruella S, Roche-Molina M, del Monte-Millán M, Marín-Aguilera M, Brasó-Maristany F, Waks AG, Pascual T, Martínez-Sáez O, Vivancos A, Conte PF, Guarneri V, Dieci MV, Griguolo G, Cortés J, Llombart-Cussac A, Muñoz M, Vidal M, Adamo B, Wolff AC, DeMichele A, Villagrasa P, Parker JS, Perou CM, Fernandez-Martinez A, Carey LA, Mittendorf EA, Martín M, Prat A, Tolaney SM, Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer, Annals of Oncology (2023), doi: https://doi.org/10.1016/j.annonc.2023.05.012. Ou https://www.annalsofoncology.org/article/S0923-7534(23)00721-4/fulltext Chou, Loretta B. MD; Johnson, Brianna MD; Shapiro, Lauren M. MD, MS; Pun, Stephanie MD; Cannada, Lisa K. MD; Chen, Antonia F. MD, MBA; Valone, Lindsey C. MD; Van Nortwick, Sara S. MD; Ladd, Amy L. MD; Finlay, Andrea K. PhD. Increased Prevalence of Breast and All-cause Cancer in Female Orthopaedic Surgeons. JAAOS: Global Research and Reviews 6(5):e22.00031, May 2022. | DOI: 10.5435/JAAOSGlobal-D-22-00031 https://journals.lww.com/jaaosglobal/Fulltext/2022/05000/Increased_Prevalence_of_Breast_and_All_cause.10.aspx